{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:24:10Z","timestamp":1786987450850,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3UL1TR002378-05S2"],"award-info":[{"award-number":["3UL1TR002378-05S2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK125013"],"award-info":[{"award-number":["P30DK125013"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Cystic Fibrosis Research Foundation","doi-asserted-by":"publisher","award":["CC002-AD"],"award-info":[{"award-number":["CC002-AD"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.conctc.2024.101278","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T10:01:28Z","timestamp":1708250488000},"page":"101278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-4594","authenticated-orcid":false,"given":"Alisa K.","family":"Sivapiromrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-9136","authenticated-orcid":false,"given":"Pichatorn","family":"Suppakitjanusant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-1917","authenticated-orcid":false,"given":"Yanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Binongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1882-7132","authenticated-orcid":false,"given":"William R.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaan","family":"Jathal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Chassaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Gewirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-5853","authenticated-orcid":false,"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.conctc.2024.101278_bib1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1164\/rccm.200701-160UP","article-title":"Update in cystic fibrosis 2006","volume":"175","author":"Accurso","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.conctc.2024.101278_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.conctc.2024.101278_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/metabo11020123","article-title":"Impact of altered gut microbiota and its metabolites in cystic fibrosis","volume":"11","author":"Thavamani","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.conctc.2024.101278_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.conctc.2024.101278_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061176","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients","volume":"8","author":"Schippa","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.conctc.2024.101278_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/gmic.22430","article-title":"Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota","volume":"4","author":"Lynch","year":"2013","journal-title":"Gut Microb."},{"issue":"1","key":"10.1016\/j.conctc.2024.101278_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.conctc.2024.101278_bib8","first-page":"515","article-title":"Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk","volume":"18","author":"Murphy","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.conctc.2024.101278_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JCM.02555-14","article-title":"Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period","volume":"53","author":"Stokell","year":"2015","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.conctc.2024.101278_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.conctc.2024.101278_bib11","first-page":"43","article-title":"Gastrointestinal manifestations of cystic fibrosis","volume":"12","author":"Sabharwal","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.conctc.2024.101278_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1073\/pnas.1714373115","article-title":"Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis","volume":"115","author":"Matamouros","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.conctc.2024.101278_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The altered gut microbiota in adults with cystic fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiol."},{"issue":"4","key":"10.1016\/j.conctc.2024.101278_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"6","key":"10.1016\/j.conctc.2024.101278_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198457","article-title":"Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis","volume":"13","author":"de Freitas","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.conctc.2024.101278_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12519-017-0033-6","article-title":"Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials","volume":"13","author":"Nikniaz","year":"2017","journal-title":"World J. Pediatr."},{"issue":"2","key":"10.1016\/j.conctc.2024.101278_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","article-title":"Dietary fiber and prebiotics and the gastrointestinal microbiota","volume":"8","author":"Holscher","year":"2017","journal-title":"Gut Microb."},{"key":"10.1016\/j.conctc.2024.101278_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.carbpol.2016.04.020","article-title":"Inulin: properties, health benefits and food applications","volume":"147","author":"Shoaib","year":"2016","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.conctc.2024.101278_bib19","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/gutjnl-2016-313271","article-title":"Prebiotic inulin-type fructans induce specific changes in the human gut microbiota","volume":"66","author":"Vandeputte","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.conctc.2024.101278_bib20","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.3390\/nu10020201","article-title":"The effect of oligofructose-enriched inulin on faecal bacterial counts and microbiota-associated characteristics in celiac disease children following a gluten-free diet: results of a randomized, placebo-controlled trial","volume":"10","author":"Drabi\u0144ska","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.conctc.2024.101278_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2017.05.055","article-title":"Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity","volume":"153","author":"Nicolucci","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.conctc.2024.101278_bib22","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.3390\/nu10030286","article-title":"Galacto-oligosaccharide\/polidextrose enriched formula protects against respiratory infections in infants at high risk of atopy: a randomized clinical trial","volume":"10","author":"Ranucci","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.conctc.2024.101278_bib23","doi-asserted-by":"crossref","first-page":"e1533","DOI":"10.1542\/peds.2013-3598","article-title":"Follow-up formula consumption in 3- to 4-year-olds and respiratory infections: an RCT","volume":"133","author":"Li","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.conctc.2024.101278_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2016.11.001","article-title":"Role of vitamin D on gut microbiota in cystic fibrosis","volume":"175","author":"Kanhere","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.conctc.2024.101278_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.metabol.2017.02.006","article-title":"Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: a pilot randomized study of high-dose vitamin D3 administration","volume":"70","author":"Alvarez","year":"2017","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.conctc.2024.101278_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/jc.2017-01983","article-title":"Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial","volume":"103","author":"Kanhere","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.conctc.2024.101278_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77806-4","article-title":"The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.conctc.2024.101278_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1751-2980.12591","article-title":"Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls","volume":"19","author":"Sch\u00e4ffler","year":"2018","journal-title":"J. Dig. Dis."},{"issue":"12","key":"10.1016\/j.conctc.2024.101278_bib29","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"CFRD Consensus Conference Committee. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.conctc.2024.101278_bib30","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","article-title":"Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified","volume":"25","author":"Bruno","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"5\u20136","key":"10.1016\/j.conctc.2024.101278_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00335-015-9560-4","article-title":"Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome","volume":"26","author":"Bazett","year":"2015","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.conctc.2024.101278_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2015.09.013","article-title":"Treatment of vitamin D deficiency in cystic fibrosis","volume":"164","author":"Chesdachai","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.conctc.2024.101278_bib33","article-title":"A Clinician's guide to vitamin D supplementation for patients with cystic fibrosis","volume":"26","author":"Wood","year":"2021","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"Suppl 2","key":"10.1016\/j.conctc.2024.101278_bib34","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jcf.2019.08.022","article-title":"Vitamin D deficiency and its treatment in cystic fibrosis","volume":"18","author":"Daley","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.conctc.2024.101278_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2265.2008.03216.x","article-title":"Vitamin D and bone health in adults with cystic fibrosis","volume":"69","author":"Wolfenden","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"10.1016\/j.conctc.2024.101278_bib36","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.3390\/nu13114048","article-title":"Vitamin D status and risk of cystic fibrosis-related diabetes: a retrospective single center cohort study","volume":"13","author":"Peng","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.conctc.2024.101278_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4161\/derm.20332","article-title":"Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: a randomized, controlled trial","volume":"4","author":"Grossmann","year":"2012","journal-title":"Dermatoendocrinol"},{"issue":"4","key":"10.1016\/j.conctc.2024.101278_bib38","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.conctc.2024.101278_bib39","article-title":"Vitamin D supplementation for cystic fibrosis","author":"Ferguson","year":"2014","journal-title":"Chrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.conctc.2024.101278_bib40","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1210\/jc.2008-2012","article-title":"Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light","volume":"94","author":"Khazai","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.conctc.2024.101278_bib41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2146\/ajhp090168","article-title":"Probiotics","volume":"67","author":"Williams","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"10","key":"10.1016\/j.conctc.2024.101278_bib42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.ejhg.5200850","article-title":"Demographics of the UK cystic fibrosis population: implications for neonatal screening","volume":"10","author":"McCormick","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.conctc.2024.101278_bib43","article-title":"A Clinician's guide to vitamin D supplementation for patients with cystic fibrosis","volume":"26","author":"Wood","year":"2021","journal-title":"J. Clin. Transl. Endocrinol."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:11:12Z","timestamp":1762521072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865424000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"alternative-id":["S2451865424000255"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101278","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.04.24300860","asserted-by":"object"}]},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101278"}}